ICD-10 Coding for Essential Thrombocytosis(D47.3, D47.3B, D47.3E)
Learn about essential thrombocytosis, its ICD-10 coding (D47.3), documentation requirements, and differentiation from reactive thrombocytosis.
Complete code families applicable to Essential Thrombocytosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.3 | Essential (hemorrhagic) thrombocythemia | Use when documentation specifies essential or primary thrombocythemia with supporting lab results. |
|
| D75.838 | Other specified thrombocytosis | Use when thrombocytosis is secondary to another condition, such as infection or inflammation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEssential Thrombocytosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Essential Thrombocytosis.
Documenting 'thrombocytosis' without specifying type
Impact
Clinical: Potential misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Claim denials due to insufficient documentation.
Mitigation
Educate providers on documentation requirements, Implement checklist for thrombocytosis documentation
Coding D47.3 without confirming genetic markers
Impact
Reimbursement: Potential denial of claims due to lack of supporting documentation., Compliance: Non-compliance with coding guidelines requiring specific documentation., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Ensure documentation includes genetic testing results or query the provider.
Genetic Testing Documentation
Impact
Lack of genetic testing documentation for essential thrombocythemia.
Mitigation
Ensure all cases of D47.3 have documented genetic test results.